phenylbutazone has been researched along with sulfacetamide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gozalbes, R; Pineda-Lucena, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Bachratá, M; Bezáková, Z; Knazko, L; Subert, J | 1 |
Jánoska, A; Sinka, L | 1 |
ARNOLD, H; DELBRUECK, A; HARTMANN, F | 1 |
5 other study(ies) available for phenylbutazone and sulfacetamide
Article | Year |
---|---|
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Determination of weak-acid drugs using a volumetric solution of sodium hydridoborate].
Topics: Acids; Benzoates; Borates; Indicators and Reagents; Phenobarbital; Phenylbutazone; Potentiometry; Solvents; Sulfacetamide; Sulfathiazoles | 1976 |
[Bullous drug exanthemata with special regard to toxic epidermal necrolysis (Lyell)].
Topics: Adult; Aged; Aminopyrine; Blister; Drug-Related Side Effects and Adverse Reactions; Erythema; Female; Humans; Male; Middle Aged; Phenylbutazone; Stevens-Johnson Syndrome; Sulfacetamide | 1969 |
[CONTRIBUTION TO THE BIOCHEMISTRY OF AN EXPERIMENTAL LIVER CIRRHOSIS AND ON THE POSSIBILITY OF CONTROLLING IT PHARMACOLOGICALLY].
Topics: Animals; Biochemical Phenomena; Biochemistry; Collagen; Cortisone; Glycosaminoglycans; Hexosamines; Hydroxyproline; Liver Cirrhosis; Liver Cirrhosis, Experimental; Nandrolone; Phenylbutazone; Rats; Research; Sulfacetamide; Toxicology | 1963 |